UCSF just launched one of the first trials to test whether attacking two proteins simultaneously can slow or stop Alzheimer's ...

UCSF is rolling out an aggressive new play in the fight against Alzheimer’s, launching a nationwide clinical trial that pairs ...

Antiamyloid drugs clear amyloid plaques and modestly slow cognitive decline in patients with Alzheimer’s disease, but whether ...

Alcohol use has been associated with an increased risk of cognitive decline and dementia. But new research from Texas A&M ...

Using animal models representing isolated features of the disease, the team discovered that alcohol dramatically reduces ...

UCSF has launched the Alzheimer's Tau Platform (ATP) trial, the first large-scale clinical trial testing combination therapies that target both amyloid plaques and tau tangles simultaneously.

The aging brain frequently harbors multiple protein pathologies that contribute to Alzheimer's, Parkinson's and other ...

We spend a lot of time searching for the ultimate secret to keeping our minds sharp as we age. We buy crossword puzzles, try ...